HIV Infection among Transgender Women: Challenges and Opportunities

摘要: Copyright: © 2014 Kerr T, et al. This is an open-access article distributed under the terms of Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided original author source are credited. Impressive gains continue to be made global fight against HIV disease. Notably, a new growing body observational experimental evidence has revealed powerful role that antiretroviral therapy can play reducing not only morbidity mortality at individual level, but also transmission population level [1,2]. led renewed calls for aggressive scale-up treatment, have been supported by array cost effectiveness studies prompted slogans referring potential “AIDS-free generation”. In addition, several demonstrated efficacy pre-exposure prophylaxis (PrEP) among HIVnegative individuals risk, although fears regarding low adherence implementation challenges resulted uptake this intervention. 2013, US Centers Disease Control Prevention released from Bangkok Tenofovir Study suggesting benefits PrEP interventions could likely extended people who inject drugs [3]. trial built upon results previous reporting on men sex with heterosexually active women [4-6].